Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
Third Amended and Restated 2014 Plan
As further described in Item 5.07 of this current report on Form 8-K, on October
29, 2020, the shareholders of Quotient Limited ("we", "us" and "our" or the
"Company") approved a third amendment and restatement of the Quotient Limited
2014 Stock Incentive Plan (as amended and restated, the "Third Amended and
Restated 2014 Plan"), which reflects amendments to the Second Amended and
Restated 2014 Stock Incentive Plan (the "2014 Plan") to (a) increase the number
of ordinary shares authorized for issuance by 750,000 shares and to increase the
maximum number of shares that may be issued upon the exercise of incentive stock
options by 750,000 shares, and (b) modify the "evergreen" provision, pursuant to
which the aggregate number of shares authorized for issuance will be
automatically increased each year beginning on April 1, 2021 by 0.75% of the
number of ordinary shares issued and outstanding on the immediately preceding
March 31, or such lesser number of shares as determined by the Board or the
remuneration committee. A description of the Third Amended and Restated 2014
Plan is set forth in the Company's Definitive Proxy Statement on Schedule 14A
filed with the SEC on July 27, 2020 (the "Proxy Statement") in the section
entitled "Approval Of The Third Amended And Restated 2014 Plan, Which Reflects
Amendments To The 2014 Plan To (A) Increase The Number Of Ordinary Shares
Authorized For Issuance By 750,000 Shares And To Increase The Maximum Number Of
Shares That May Be Issued Upon The Exercise Of Incentive Stock Options By
750,000 Shares, And (B) Modify The "Evergreen" Provision, Pursuant To Which The
Aggregate Number Of Shares Authorized For Issuance Will Be Automatically
Increased Each Year Beginning On April 1, 2021 By 0.75% Of The Number Of
Ordinary Shares Issued And Outstanding On The Immediately Preceding March 31, Or
Such Lesser Number Of Shares As Determined By Our Board Or The Remuneration
Committee (Resolution 11)," which description is incorporated herein by
reference. The description is qualified in its entirety by reference to the full
text of the Third Amended and Restated 2014 Plan, a copy of which is attached to
the Proxy Statement as Exhibit A and which is filed as Exhibit 10.1 to this
Current Report on Form 8-K and incorporated herein by reference.
Share Option Grants Made to Certain Executive Officers
As disclosed in the Proxy Statement, the Company's remuneration committee
previously recommended to the board of directors (the "Board") that the Company
grant 20,000 option awards to Peter Buhler, our Chief Financial Officer, 20,000
option awards to Edward Farrell, our Chief Operating Officer, and 30,000 option
awards to Jeremy Stackawitz, our Chief Commercial Officer (the "Option Awards"),
contingent upon the adoption of the Third Amended and Restated 2014 Plan. The
Board subsequently approved the Option Awards and we granted the Option Awards
on October 31, 2020. Each Option Award will have an exercise price of $4.72,
which is the closing sale price of the Company's ordinary shares on The Nasdaq
Global Market on the grant date. The Option Awards are subject to three year
vesting, and will vest in equal installments on the first, second and third
anniversary of the grant.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On October 29, 2020, the annual general meeting of shareholders (the "Annual
Meeting") of the Company was held at which 69,147,426 of the Company's ordinary
shares were represented in person or by proxy, representing approximately
85.73 % of the Company's issued and outstanding ordinary shares entitled to
vote. At the Annual Meeting, resolutions were passed for (i) the re-election of
eight directors of the Company, (ii) the approval, on a non-binding, advisory
basis, of the compensation paid to our named executive officers, as described in
the "Compensation Discussion and Analysis" section of the Proxy Statement, and
the related compensation tables, notes and narrative discussion, (iii) the
determination, on a non-binding, advisory basis, of the frequency of every year
for future shareholder advisory votes to approve the compensation paid to our
named executive officers, (iv) the approval of the Third Amended and Restated
2014 Plan, which reflects amendments to the 2014 Plan to (a) increase the number
of ordinary shares authorized for issuance by 750,000 shares and to increase the
maximum number of shares that may be issued upon the exercise of incentive stock
options by 750,000 shares, and (b) modify the "evergreen" provision, pursuant to
which the aggregate number of shares authorized for issuance will be
automatically increased each year beginning on April 1, 2021 by 0.75% of the
number of ordinary shares issued and outstanding on the immediately preceding
March 31, or such lesser number of shares as determined by the Board or the
remuneration committee, and (v) the re-appointment of Ernst & Young LLP as
auditors to hold office from the conclusion of the Annual Meeting until the next
annual general meeting of shareholders to be held in 2021, the ratification of
the appointment of Ernst & Young LLP as the Company's independent registered
public accounting firm for purposes of the United States Securities law
reporting for the fiscal year ending March 31, 2021, and the authorization of
the directors to determine the fees to be paid to the auditors. These matters
are described in more detail in the Proxy Statement.
The votes cast in respect of each resolution were as follows:
--------------------------------------------------------------------------------
To re-elect eight members to the Board
of Directors
Director Nominees Votes Votes Broker
For Withheld Non-Votes
Franz Walt 60,617,915 799,490 7,730,021
Isabelle Buckle 59,857,227 1,560,178 7,730,021
Frederick Hallsworth 59,998,574 1,418,831 7,730,021
Catherine Larue 59,858,080 1,559,325 7,730,021
Brian McDonough 57,930,482 3,486,923 7,730,021
Heino von Prondzynski 57,627,799 3,489,606 7,730,021
Zubeen Shroff 57,925,740 3,491,665 7,730,021
John Wilkerson 59,997,898 1,419,507 7,730,021
Votes Votes Votes Broker Non-Votes
For Against Abstained
Non-binding, advisory vote to approve
the compensation paid to the Company's
named executive officers, as described
in the "Compensation Discussion and 50,999,568 9,888,397 529,440 7,730,021
Analysis" section of the Company's
proxy statement and the related
compensation tables, notes and
narrative discussion
Votes for Votes for Votes for
Every 1 Every 2 Every 3 Votes Abstained
year years years
Non-binding, advisory vote to determine
the frequency of future advisory votes 59,969,777 62,627 96,618 1,288,383
to approve the compensation paid to the
Company's named executed officers.
Votes Votes Votes Broker Non-Votes
For Against Abstained
To approve the Third Amended and
Restated 2014 Plan, which reflects
amendments to the 2014 Plan to (a)
increase the number of ordinary shares
authorized for issuance by 750,000
shares and to increase the maximum
number of shares that may be issued
upon the exercise of incentive stock
options by 750,000 shares and (b)
modify the "evergreen" provision, 35,622,318 25,272,089 522,998 7,730,021
pursuant to which the aggregate number
of shares authorized for issuance will
be automatically increased each year
beginning on April 1, 2020 by 0.75% of
the number of ordinary shares issued
and outstanding on the immediately
preceding March 31, or such lesser
number of shares as determined by the
Company's Board of Directors or the
remuneration committee
Votes For Votes Votes
Against Abstained
To re-appoint Ernst & Young LLP as
auditors to hold office from the
conclusion of the Annual Meeting until
the next annual general meeting of
shareholders to be held in 2021, to
ratify the appointment of Ernst & Young
LLP as the Company's independent 68,888,499 180,598 78,329
registered public accounting firm for
purposes of the United States
Securities law reporting for the fiscal
year ending March 31, 2021, and to
authorize the directors to determine
the fees to be paid to the auditors
Consistent with the recommendation of the directors and the vote of the
Company's shareholders, the Company has determined that future advisory votes to
approve the compensation of the Company's named executive officers will take
place every year until the next
--------------------------------------------------------------------------------
advisory vote on the frequency of such votes, which will occur no later than the
Company's annual general meeting of shareholders to be held in 2026.
Item 9.01. Financial Statements and Exhibits
Set forth below is a list of Exhibits included as part of this Current Report.
Exhibit Description
10.1 Quotient Limited 2014 Stock Incentive Plan, as adopted on March 31,
2014, amended and restated on October 28, 2016, further amended and
restated on October 31, 2018, and further amended and restated on
October 29, 2020
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses